DrugPatentWatch Database Preview
PROPRANOLOL HYDROCHLORIDE Drug Profile
Email this page to a colleague
» See Plans and PricingWhich patents cover Propranolol Hydrochloride, and what generic alternatives are available?
Propranolol Hydrochloride is a drug marketed by Actavis Elizabeth, Adare Pharms Inc, Amta, Inwood Labs, Mylan, Nortec Dev Assoc, Upsher Smith Labs, Zydus Pharms Usa Inc, Athenex Inc, Baxter Hlthcare Corp, Fosun Pharma, Fresenius Kabi Usa, Hikma Farmaceutica, Smith And Nephew, Solopak, Hikma, Morton Grove, Ani Pharms Inc, Dava Pharms Inc, Duramed Pharms Barr, Impax Labs Inc, Innogenix, Interpharm, Ipca Labs Ltd, Ivax Sub Teva Pharms, Lederle, Northstar Hlthcare, Par Pharm, Purepac Pharm, Roxane, Sandoz, Schering, Superpharm, Teva, Vintage Pharms, Warner Chilcott, Watson Labs, Watson Labs Teva, and Yaopharma Co Ltd. and is included in one hundred and forty NDAs.
The generic ingredient in PROPRANOLOL HYDROCHLORIDE is hydrochlorothiazide; propranolol hydrochloride. There are thirty-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the hydrochlorothiazide; propranolol hydrochloride profile page.
Summary for PROPRANOLOL HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 39 |
| NDAs: | 140 |
| Suppliers / Packagers: | 36 |
| Bulk Api Vendors: | 113 |
| Clinical Trials: | 264 |
| Patent Applications: | 3,287 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | PROPRANOLOL HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for PROPRANOLOL HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Shanghai Children's Medical Center | Phase 4 |
| Foundation for Anesthesia Education and Research | Phase 2 |
| Duke University | Phase 2 |
Pharmacology for PROPRANOLOL HYDROCHLORIDE
| Drug Class | beta-Adrenergic Blocker |
| Mechanism of Action | Adrenergic beta-Antagonists |
Medical Subject Heading (MeSH) Categories for PROPRANOLOL HYDROCHLORIDE
Paragraph IV (Patent) Challenges for PROPRANOLOL HYDROCHLORIDE
| Tradename | Dosage | Ingredient | NDA | Submissiondate |
|---|---|---|---|---|
| INDERAL LA | CAPSULE, EXTENDED RELEASE;ORAL | propranolol hydrochloride | 018553 |
US Patents and Regulatory Information for PROPRANOLOL HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interpharm | PROPRANOLOL HYDROCHLORIDE | propranolol hydrochloride | TABLET;ORAL | 071371-001 | May 5, 1987 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Purepac Pharm | PROPRANOLOL HYDROCHLORIDE | propranolol hydrochloride | TABLET;ORAL | 070816-001 | Nov 3, 1986 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Hikma | PROPRANOLOL HYDROCHLORIDE | propranolol hydrochloride | SOLUTION;ORAL | 070979-001 | May 15, 1987 | RX | No | Yes | Start Trial | Start Trial | Start Trial | ||||
| Zydus Pharms Usa Inc | PROPRANOLOL HYDROCHLORIDE | propranolol hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 090321-004 | Mar 25, 2011 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
